PROSPECTS FOR INCREASING THE EFFICIENCY OF TREATMENT OF PATIENTS HEAVING OF LOCALLY- DISTRIBUTED BREAST CANCER

Improving the efficiency of treatment of locally distributed forms of breast cancer (BC) patients is relevant. The aim of the study: to determine the possibility of increasing the efficiency of treatment of patients with locally distributed BC by supplementing it with the determination of the exp...

Full description

Bibliographic Details
Main Authors: Yuriy Vinnik, Yulia Belevtsova, Marina Sadchikova
Format: Article
Language:English
Published: Scientific Route OÜ 2020-05-01
Series:EUREKA: Health Sciences
Subjects:
Online Access:http://journal.eu-jr.eu/health/article/view/1286
id doaj-6010f7176884419db3f2873425385a8b
record_format Article
spelling doaj-6010f7176884419db3f2873425385a8b2020-11-25T03:13:11ZengScientific Route OÜEUREKA: Health Sciences2504-56602504-56792020-05-01361210.21303/2504-5679.2020.0012861286PROSPECTS FOR INCREASING THE EFFICIENCY OF TREATMENT OF PATIENTS HEAVING OF LOCALLY- DISTRIBUTED BREAST CANCERYuriy Vinnik0Yulia Belevtsova1Marina Sadchikova2Kharkiv Medical Academy of Postgraduate EducationKharkiv Medical Academy of Postgraduate EducationKharkiv Medical Academy of Postgraduate EducationImproving the efficiency of treatment of locally distributed forms of breast cancer (BC) patients is relevant. The aim of the study: to determine the possibility of increasing the efficiency of treatment of patients with locally distributed BC by supplementing it with the determination of the expression of TOP2 alpha and beta-tubulin III genes in the primary tumor during various chemotherapy regimens. Method. 139 patients with locally distributed BC were examined. Patients received 2-4 courses of neoadjuvant chemotherapy (NAChT) according to the TC (docetaxel + cyclophosphamide) and TAC (docetaxel + doxorubicin + cyclophosphamide) regimens, subsequent surgical intervention and 2–4 courses of AchT according to the FAC regimen. Immunohistochemical (IHCh) study of the levels of estrogen receptors (ER), progesterone (PR), epidermal growth factor (HER2) in tumors was conducted. The expression of TOP2 alpha and beta-tubulin class III genes was determined using PCR. Statistical data processing was performed using the program Stastistica for Windows 6. 0, Excel. Results. In the third cycle of chemotherapy, patients were transferred from the TC scheme to the TAC scheme. The frequency of the FPR increased 4 times in the group of patients with a triple negative tumor subtype compared with patients with luminal B. A combination of low expression of the class III beta-tubulin gene with high expression of TOP2 alpha in tumor tissue was found in 64.5 % of patients treated according to the TAC + cross over regimen and in 56.3 % of cases according to the TC regimen. A change in the receptor status of MLN after NAChT was detected in some cases. Conclusions. The combination of high expression of TOP2 alpha with low expression of class III beta-tubulins can be considered as a predictive sign of full pathomorphological response when using taxane-containing locally distributed BC. These markers can be recommended for determination in MLN (along with definition of ER, PR, HER2) in order to increase the effectiveness of AchT.http://journal.eu-jr.eu/health/article/view/1286locally distributed breast cancer; chemotherapy; estrogen; progesterone receptors; her2; lymph nodes; topoisomerase ii alpha; beta-tubulin iii
collection DOAJ
language English
format Article
sources DOAJ
author Yuriy Vinnik
Yulia Belevtsova
Marina Sadchikova
spellingShingle Yuriy Vinnik
Yulia Belevtsova
Marina Sadchikova
PROSPECTS FOR INCREASING THE EFFICIENCY OF TREATMENT OF PATIENTS HEAVING OF LOCALLY- DISTRIBUTED BREAST CANCER
EUREKA: Health Sciences
locally distributed breast cancer; chemotherapy; estrogen; progesterone receptors; her2; lymph nodes; topoisomerase ii alpha; beta-tubulin iii
author_facet Yuriy Vinnik
Yulia Belevtsova
Marina Sadchikova
author_sort Yuriy Vinnik
title PROSPECTS FOR INCREASING THE EFFICIENCY OF TREATMENT OF PATIENTS HEAVING OF LOCALLY- DISTRIBUTED BREAST CANCER
title_short PROSPECTS FOR INCREASING THE EFFICIENCY OF TREATMENT OF PATIENTS HEAVING OF LOCALLY- DISTRIBUTED BREAST CANCER
title_full PROSPECTS FOR INCREASING THE EFFICIENCY OF TREATMENT OF PATIENTS HEAVING OF LOCALLY- DISTRIBUTED BREAST CANCER
title_fullStr PROSPECTS FOR INCREASING THE EFFICIENCY OF TREATMENT OF PATIENTS HEAVING OF LOCALLY- DISTRIBUTED BREAST CANCER
title_full_unstemmed PROSPECTS FOR INCREASING THE EFFICIENCY OF TREATMENT OF PATIENTS HEAVING OF LOCALLY- DISTRIBUTED BREAST CANCER
title_sort prospects for increasing the efficiency of treatment of patients heaving of locally- distributed breast cancer
publisher Scientific Route OÜ
series EUREKA: Health Sciences
issn 2504-5660
2504-5679
publishDate 2020-05-01
description Improving the efficiency of treatment of locally distributed forms of breast cancer (BC) patients is relevant. The aim of the study: to determine the possibility of increasing the efficiency of treatment of patients with locally distributed BC by supplementing it with the determination of the expression of TOP2 alpha and beta-tubulin III genes in the primary tumor during various chemotherapy regimens. Method. 139 patients with locally distributed BC were examined. Patients received 2-4 courses of neoadjuvant chemotherapy (NAChT) according to the TC (docetaxel + cyclophosphamide) and TAC (docetaxel + doxorubicin + cyclophosphamide) regimens, subsequent surgical intervention and 2–4 courses of AchT according to the FAC regimen. Immunohistochemical (IHCh) study of the levels of estrogen receptors (ER), progesterone (PR), epidermal growth factor (HER2) in tumors was conducted. The expression of TOP2 alpha and beta-tubulin class III genes was determined using PCR. Statistical data processing was performed using the program Stastistica for Windows 6. 0, Excel. Results. In the third cycle of chemotherapy, patients were transferred from the TC scheme to the TAC scheme. The frequency of the FPR increased 4 times in the group of patients with a triple negative tumor subtype compared with patients with luminal B. A combination of low expression of the class III beta-tubulin gene with high expression of TOP2 alpha in tumor tissue was found in 64.5 % of patients treated according to the TAC + cross over regimen and in 56.3 % of cases according to the TC regimen. A change in the receptor status of MLN after NAChT was detected in some cases. Conclusions. The combination of high expression of TOP2 alpha with low expression of class III beta-tubulins can be considered as a predictive sign of full pathomorphological response when using taxane-containing locally distributed BC. These markers can be recommended for determination in MLN (along with definition of ER, PR, HER2) in order to increase the effectiveness of AchT.
topic locally distributed breast cancer; chemotherapy; estrogen; progesterone receptors; her2; lymph nodes; topoisomerase ii alpha; beta-tubulin iii
url http://journal.eu-jr.eu/health/article/view/1286
work_keys_str_mv AT yuriyvinnik prospectsforincreasingtheefficiencyoftreatmentofpatientsheavingoflocallydistributedbreastcancer
AT yuliabelevtsova prospectsforincreasingtheefficiencyoftreatmentofpatientsheavingoflocallydistributedbreastcancer
AT marinasadchikova prospectsforincreasingtheefficiencyoftreatmentofpatientsheavingoflocallydistributedbreastcancer
_version_ 1724648254696587264